Heghine Khachatryan on a Milestone for Platelet Disorders: CRISPR Assays Transform Variant Classification
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, reposted Jesse Rowley’s article on LinkedIn:
“Functional classification of platelet gene variants using CRISPR HDR in CD34+ cell-derived megakaryocytes is a real milestone for inherited platelet disorders.
For clinicians managing patients with Glanzmann thrombasthenia and other platelet function defects, this type of functional assay can finally help us move from “variant of uncertain significance” to mechanistic understanding in a human megakaryocyte model.
The obvious next dream is to translate these elegant tools into safe and effective gene-therapy strategies for our patients. I’m excited to follow how this work will shape future diagnostics and treatments.”
Quoting Jesse Rowley’s post:
“Title: Functional classification of platelet gene variants using CRISPR HDR in CD34+ cell-derived megakaryocytes
Authors: Yasuhiro Kosaka, Brandon Lopez, Nina Kishimoto, Shancy Jacob, Emilie Montenont, Rodrigo Huallanca, Graeson Coughenour, Jorge Di Paola, Justyne Ross, Kristy Lee, Matthew T. Rondina, Paul F. Bray, Jesse W. Rowley
Read full article here.”
Stay updated with Hemostasis Today.
-
Mar 16, 2026, 07:26James Crowley, Professor of Medicine emeritus at Brown University, posted on LinkedIn:
-
Mar 15, 2026, 15:55Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 2
-
Mar 15, 2026, 14:09Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib – The Clinical Tightrope
-
Mar 15, 2026, 14:02Denise M: Precision Hemostasis in Patient Blood Management
-
Mar 15, 2026, 13:57Abdulrahman Nasiri: D14 Bone Marrow Biopsy in AML Induction in the Era of Targeted Therapies
-
Mar 15, 2026, 13:52Valentin Ortiz-Maldonado: High-Impact Innovation in CAR-T Therapy Can Emerge From Academic Programmes
-
Mar 15, 2026, 13:45Tareq Abadl: Has Anyone Here Ever Taken an ALP Test Before?
-
Mar 14, 2026, 21:30Ayman Elbadawi: Why Does Stent Thrombosis Still Occur? Insights from the NCDR Data
-
Mar 14, 2026, 20:03Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency